BridgeMD
Tests treatment safety and results for Adhesive Capsulitis
Official title Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis
ClinicalTrials.gov ID: NCT06176248
What this study is testing
What is Triamcinolone Acetonide?
Triamcinolone Acetonide is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for adhesive capsulitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a double-blind interventional superiority study evaluating the efficacy of suprascapular nerve block in addition to conventional therapies for adhesive capsulitis. Adhesive capsulitis is a pathology that results in reduced shoulder mobility due to retraction of the periarticular capsule.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient treated for adhesive capsulitis corresponding to a loss of passive amplitude of more than 20° in external rotation elbow to body and/or...
- Patient over 18 years of age
- Patient covered by a social security scheme
- Presence of an accompanying person on the day of the procedure for the return trip
- Patient having signed the consent form to participate in the study
You likely can't join if
- Patient protected by law
- Pregnant women
- Patient who has had shoulder surgery less than six months old
- Patient unable to undergo rehabilitation within one month of surgery
- Allergy to one of the products used (anesthetic, iodinated contrast medium)
- Neuro-orthopedic disorder hampering clinical recovery
See the full eligibility criteria
- Patient treated for adhesive capsulitis corresponding to a loss of passive amplitude of more than 20° in external rotation elbow to body and/or abduction in relation to the contralateral shoulder.
- Patient over 18 years of age
- Patient covered by a social security scheme
- Presence of an accompanying person on the day of the procedure for the return trip
- Patient having signed the consent form to participate in the study
- Patient protected by law
- Pregnant women
- Patient who has had shoulder surgery less than six months old
- Patient unable to undergo rehabilitation within one month of surgery
- Allergy to one of the products used (anesthetic, iodinated contrast medium)
- Neuro-orthopedic disorder hampering clinical recovery
- Hemostasis disorder contraindicating block (no discontinuation of anticoagulants according to SFAR recommendations, congenital hemostasis disorder)
The study team makes the final eligibility decision.
Where it's taking place
- Reims, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reims, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.